Tatiana Mularek‐Kubzdela

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2017 · 264 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy

Aleksander Araszkiewicz, Szymon Darocha, Arkadiusz Pietrasik et al. · International Journal of Cardiology · 2018 · 94 citations

Medicine, Surgery, Cardiothoracic Surgery +9

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

Grzegorz Kopeć, Marcin Kurzyna, Ewa Mroczek et al. · Journal of Clinical Medicine · 2020 · 74 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry

Szymon Darocha, Marek Roik, Grzegorz Kopeć et al. · EuroIntervention · 2022 · 61 citations · Full text

Medicine, Cardiology, Surgery +13

Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Anna Smukowska-Gorynia, Iga Tomaszewska, Katarzyna Małaczyńska-Rajpold et al. · Heart Lung and Circulation · 2017 · 39 citations

Medicine, Cell Biology, Pathology +8